Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD)
CUSIP: M47238148
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Ordinary Shares, NIS 1.80 par value per share
- Shares outstanding
- 5,591,387
- Total 13F shares
- 5,585
- Share change
- +5,584
- Total reported value
- $38,313
- Price per share
- $6.86
- Number of holders
- 9
- Value change
- +$38,306
- Number of buys
- 8
Quarterly Holders Quick Answers
What is CUSIP M47238148?
CUSIP M47238148 identifies GLMD - Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2024
Recent filing periods for CUSIP M47238148:
Top shareholders of GLMD - Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Walleye Capital LLC |
13F
|
Company |
—
class O/S missing
|
290,596
|
$83,110 | — | 30 Jun 2024 | |
| CVI Holdings, LLC |
13F
|
Company |
—
class O/S missing
|
47,239
|
$13,510 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
36,213
|
$9,959 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
class O/S missing
|
11,625
|
$3,325 | — | 30 Jun 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
10,330
|
$2,841 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
280
|
$77 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
204
|
$56 | — | 30 Jun 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
—
class O/S missing
|
167
|
$46 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
53
|
$14 | — | 30 Jun 2024 | |
| Allworth Financial LP |
13F
|
Company |
—
class O/S missing
|
17
|
$6 | — | 30 Jun 2024 | |
| ELEVATION WEALTH PARTNERS, LLC |
13F
|
Company |
—
class O/S missing
|
7
|
$2 | — | 30 Jun 2024 |
Institutional Holders of Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD) as of Q3 2024
As of 30 Sep 2024,
Galmed Pharmaceuticals Ltd. - Ordinary Shares, NIS 1.80 par value per share (GLMD) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,585 shares.
The largest 9 holders included
UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Federation des caisses Desjardins du Quebec, OSAIC HOLDINGS, INC., Allworth Financial LP, ZRC WEALTH MANAGEMENT, LLC, and BNP PARIBAS FINANCIAL MARKETS.
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
16
Q3 2024 holders
9
Holder diff
-7
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.